Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer
Min Young Baek, Hee Kyung Ahn, Kyu Ree Park, Hwa-Sun Park, Shin Myung Kang, Inkeun Park, Young Saing Kim, Junshik Hong, Sun Jin Sym, Jinny Park, Jae Hoon Lee, Dong Bok Shin, Eun Kyung Cho
Korean J Intern Med. 2018;33(1):168-175.   Published online 2016 Apr 20     DOI: https://doi.org/10.3904/kjim.2015.158
Citations to this article as recorded by Crossref logo
The role of EGFR mutation as a prognostic factor in survival after diagnosis of brain metastasis in non-small cell lung cancer: a systematic review and meta-analysis
Wen-Ya Li, Ting-Ting Zhao, Hui-Mian Xu, Zhen-Ning Wang, Ying-Ying Xu, Yunan Han, Yong-Xi Song, Jian-Hua Wu, Hao Xu, Song-Cheng Yin, Xing-Yu Liu, Zhi-Feng Miao
BMC Cancer.2019;[Epub]     CrossRef
A Comprehensive Meta-Analysis of Association between EGFR Mutation Status and Brain Metastases in NSCLC
Li Tan, Yinying Wu, Xiaowei Ma, Yanli Yan, Shuai Shao, Jiaxin Liu, Hailin Ma, Rui Liu, Linyan Chai, Juan Ren
Pathology & Oncology Research.2019;[Epub]     CrossRef
IMP3 expression in NSCLC brain metastases demonstrates its role as a prognostic factor in non-neuroendocrine phenotypes
Alessandro Del Gobbo, Annamaria Morotti, Anna Eleonora Colombo, Valentina Vaira, Giulia Ercoli, Chiara Pesenti, Eleonora Bonaparte, Elena Guerini-Rocco, Andrea Di Cristofori, Marco Locatelli, Alessandro Palleschi, Stefano Ferrero
Medical Oncology.2018;[Epub]     CrossRef
The impact of EGFR mutations on the incidence and survival of stages I to III NSCLC patients with subsequent brain metastasis
Wei-Yuan Chang, Yi-Lin Wu, Po-Lan Su, Szu-Chun Yang, Chien-Chung Lin, Wu-Chou Su, Jung Weon Lee
PLOS ONE.2018; 13(2): e0192161.     CrossRef
Therapeutic Effect of First-line Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI) Combined with Whole Brain Radiotherapy on Patients with EGFR Mutation-positive Lung Adenocarcinoma and Brain Metastases
Shao-bo Ke, Hu Qiu, Jia-mei Chen, Wei Shi, Yong-shun Chen
Current Medical Science.2018; 38(6): 1062.     CrossRef
Role of Local Ablative Therapy in Patients with Oligometastatic and Oligoprogressive Non–Small Cell Lung Cancer
Chul Kim, Chuong D. Hoang, Aparna H. Kesarwala, David S. Schrump, Udayan Guha, Arun Rajan
Journal of Thoracic Oncology.2017; 12(2): 179.     CrossRef
AXL–GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases
Xiaoliang Wu, Wenjuan Ma, Qianghua Zhou, Haijuan Yan, Zuan-Fu Lim, Mayan Huang, Chuangzhong Deng, Xingsu Yu, Huifang Su, Satoshi Komo, Haixia Yang, Xinke Zhang, Sijin Wen, Zhenfeng Zhang, Patrick C. Ma
Journal of Cancer Research and Clinical Oncology.2017; 143(10): 1947.     CrossRef
Patterns of metastatic progression after definitive radiation therapy for early-stage and locally advanced non-small cell lung cancer
Garrett L. Jensen, Chad Tang, Kenneth R. Hess, Zhongxing Liao, Daniel R. Gomez
Clinical & Experimental Metastasis.2017; 34(5): 315.     CrossRef
Brain metastases in non-small cell lung cancer patients on epidermal growth factor receptor tyrosine kinase inhibitors: symptom and economic burden
Ancilla W. Fernandes, Bingcao Wu, Ralph M. Turner
Journal of Medical Economics.2017; 20(11): 1136.     CrossRef
High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases
Mengxi Ge, Yingjie Zhuang, Xinli Zhou, Ruofan Huang, Xiaohua Liang, Qiong Zhan
Journal of Neuro-Oncology.2017; 135(2): 413.     CrossRef
EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer
Pascale Tomasini, Cindy Serdjebi, Nataliya Khobta, Philippe Metellus, L’Houcine Ouafik, Isabelle Nanni, Laurent Greillier, Anderson Loundou, Frederic Fina, Celine Mascaux, Fabrice Barlesi
International Journal of Molecular Sciences.2016; 17(12): 2132.     CrossRef